Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet disorders in pregnancy.

R F Burrows1

  • 1Monash University, Monash Medical Centre, Clayton, Victoria, Australia. robert.burrows@med.monash.edu.au

Current Opinion in Obstetrics & Gynecology
|April 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interventions for treating cholestasis in pregnancy.

The Cochrane database of systematic reviews·2001
Same author

Anticoagulation in pregnancy and the puerperium.

The Medical journal of Australia·2001
Same author

A randomised double-blind placebo controlled trial of low molecular weight heparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study.

BJOG : an international journal of obstetrics and gynaecology·2001
Same author

Platelet count may predict abnormal bleeding time among pregnant women with hypertension and preeclampsia.

Canadian journal of anaesthesia = Journal canadien d'anesthesie·2001
Same author

MOS HIP: McMaster outcome study of hypertension in pregnancy.

Early human development·2001
Same author

Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis.

The Australian & New Zealand journal of obstetrics & gynaecology·2001

Automated cell counters frequently detect thrombocytopenia in pregnant individuals. However, this condition is usually benign and rarely indicates fetal thrombocytopenia, diminishing its clinical significance.

Area of Science:

  • Hematology
  • Obstetrics
  • Perinatology

Background:

  • Historically, thrombocytopenia diagnosis relied on clinical suspicion.
  • Automated cell counters have increased the detection rate of thrombocytopenia in pregnancy.
  • The clinical significance of commonly detected thrombocytopenia in pregnancy has been overlooked.

Purpose of the Study:

  • To re-evaluate the clinical significance of thrombocytopenia in pregnancy.
  • To assess the utility of maternal thrombocytopenia as a predictor of fetal thrombocytopenia.

Main Methods:

  • Review of clinical data and diagnostic criteria for thrombocytopenia in pregnant patients.
  • Analysis of the correlation between maternal thrombocytopenia and fetal outcomes.

Related Experiment Videos

Main Results:

  • Thrombocytopenia in pregnancy is frequently identified through automated cell counting.
  • The majority of cases of thrombocytopenia in pregnant individuals are clinically benign.
  • Maternal thrombocytopenia has minimal value as an indicator of fetal thrombocytopenia.

Conclusions:

  • The widespread detection of thrombocytopenia in pregnancy by automated counters has reduced its perceived clinical importance.
  • Maternal thrombocytopenia is generally not a reliable marker for fetal thrombocytopenia.